IBIS Technologies BV Company Profile

21:36 EST 9th December 2018 | BioPortfolio

The IBIS iSPR is a novel imaging SPR instrument that allows the simultaneous monitoring of multiple binding interactions to the surface of one and the same sensor. This way, it can be used for real-time detection of the possible binding events to the many spots of a micoarray, for example. Thanks to it flexibility, the instrument can also be accomodated to be used as a, more conventionel, 1- and 2-channel measurement set-up. Two different instrument configurations are available:
1. For the 'basic configuration', the liquid system consists of a syringe pump, a drain pump and an autosampler with a double needle. This needle consists of an inner (inlet) needle that leads to a buffer bottle, and an outer (outlet) needle that leads via the drain pump to the waste bottle. The basic configuration instrument can be used in combination with a one-compartment cuvette, e.g. in the way the former 1-channel IBIS I was used, or for measuring on (micro) arrays. The system also can be used in combination with a negative pressure driven flow-cell, which is particularly useful in experiments with organic solvent.
2. For the 'plus configuration', the liquid system is extended with a second syringe pump. This configuration is very useful if one wants to use a 2-channel cuvette (comparable to the way the former IBIS II was used) or a positive pressure driven flow-cell.


PO Box 1242
7550 BE


Phone: 31 74 259 02 66
Fax: 31 74 256 70 47

News Articles [230 Associated News Articles listed on BioPortfolio]

How Senscio Systems addresses chronic care management with AI

The company’s Ibis platform goes in the homes of patients with multiple chronic conditions. Individuals interact with it, and Ibis sends necessary information to the patient’s care team.

'Bin chicken' plays unique role in story of evolution

(University of Queensland) A University of Queensland researcher has uncovered how a French scientist and ibis researcher conducted the first test of evolution more than 50 years before Charles Darwin...

Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ

How Sacred Ibis mummies provided the first test of evolution

(PLOS) A debate over mummified birds brought to France after Napoleon's conquest of Egypt played a central role in delaying acceptance of evolutionary theory; an episode in the history of biology reve...

BioStem Technologies filing four pre-investigational new drug applications by end of year

BioStem Technologies, Inc. is a global life sciences corporation, providing innovative technologies with a concentration in Pharmaceuticals and Regenerative Medicine.

Incessant Technologies est citée comme une entreprise très performante par un cabinet de ...

HYDERABAD, Inde, October 4, 2018 /PRNewswire/ -- Incessant Technologies, une entreprise de NIIT Technologies, a été parmi les sociétés que Forrester a choisi d'inviter à Read more...

2m Seed Funding Raised For Life Sciences

Investment manager Deepbridge Capital has today announced the £2m funding of 12 seed stage life sciences companies.Deepbridge raised funds via the Deepbridge Life Sciences SEIS proposition, laun...

United Technologies Receives Final Regulatory Approval To Close Rockwell Deal

HARTFORD (dpa-AFX) - United Technologies Corp. (UTX) announced the conclusion of the regulatory review by China's State Administration for Market Regulation clears the way for United Technologies ...

PubMed Articles [325 Associated PubMed Articles listed on BioPortfolio]

The Sacred Ibis debate: The first test of evolution.

In 1798, Napoleon Bonaparte's army invaded Egypt, returning with many treasures including large numbers of Sacred Ibis mummies. The ancient Egyptians revered the ibis and mummified literally millions ...

Correction: The Sacred Ibis debate: The first test of evolution.

[This corrects the article DOI: 10.1371/journal.pbio.2005558.].

Correction: The cultivable autochthonous microbiota of the critically endangered Northern bald ibis (Geronticus eremita).

[This corrects the article DOI: 10.1371/journal.pone.0195255.].

Adoption of Stroke Rehabilitation Technologies by the User Community: Qualitative Study.

Using technology in stroke rehabilitation is attractive. Devices such as robots or smartphones can help deliver evidence-based levels of practice intensity and automated feedback without additional la...

Application of Digital Technologies in Maxillofacial Prosthetics Literature: A 10-Year Observation of Five Selected Prosthodontics Journals.

To identify trends in the application of various types of digital technologies in maxillofacial prosthetics by identifying these digital technologies and their characteristics and reviewing the preval...

Clinical Trials [461 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

Incidence and Economic Burden of Clostridium Difficile Infections (CDI) in the German Health Care System (IBIS)

IBIS is a prospective, observational study, which aims to assess the cost of CDI per day, hospitalization and year including description of incremental costs in hospitalized patients, and ...

Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS

RATIONALE: Bisphosphonates, such as risedronate, may help improve bone health and prevent osteoporosis in postmenopausal women. It is not yet known whether risedronate is effective in impr...

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Companies [1284 Associated Companies listed on BioPortfolio]

IBIS Technologies BV

The IBIS iSPR is a novel imaging SPR instrument that allows the simultaneous monitoring of multiple binding interactions to the surface of one and the same sensor. This way, it can be used for real-ti...

Isis Pharmaceuticals

Isis Pharmaceuticals, Inc. is a leading drug discovery and development company, focused exclusively on the therapeutic target, RNA. Founded in 1989, Isis' mission is to develop products from its RNA-b...


MedicineWorks(TM), a division of Health Resources Unlimited, Inc., produces medical reference and health education tools for professionals and the public. InteractionsGuide(TM) builds on work begun tw...

LVL Technologies, Inc.

LVL Technologies, Inc. was founded by Dr. Dustin Freckleton and Nithin Rajan with a mission of bringing the accuracy of medical device technologies to the consumer wearables marke...

CA Technologies

CA Technologies (NASDAQ: CA) is an IT management software and solutions company with expertise across all IT environments - from mainframe and distributed, to virtual and cloud. For additional inf...

More Information about "IBIS Technologies BV" on BioPortfolio

We have published hundreds of IBIS Technologies BV news stories on BioPortfolio along with dozens of IBIS Technologies BV Clinical Trials and PubMed Articles about IBIS Technologies BV for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of IBIS Technologies BV Companies in our database. You can also find out about relevant IBIS Technologies BV Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record